# FDA Inspection 1191022 - Ascension Health - October 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/ascension-health/eca8ebcd-8f8e-4efe-b2e6-d14202bb1cd1
Source feed: FDA_Inspections

> FDA Inspection 1191022 for Ascension Health on October 13, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1191022
- Company Name: Ascension Health
- Inspection Date: 2022-10-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276328 - 2025-07-10](https://www.keypedia.com/records/fda_inspections/ascension-health/8acd8d9e-81ff-44d1-9c43-8d55322fbd2d)
- [FDA Inspection 1276328 - 2025-07-10](https://www.keypedia.com/records/fda_inspections/ascension-health/c94e68e9-9277-4568-8367-61337509253c)
- [FDA Inspection 1191022 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/ascension-health/a415d933-85ae-42f3-9228-b74751feaa85)
- [FDA Inspection 1037436 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/ascension-health/f0d9dc85-c1d5-479a-b422-42236b106b9b)
- [FDA Inspection 952132 - 2015-12-09](https://www.keypedia.com/records/fda_inspections/ascension-health/44747cd0-3a8a-4cd4-913b-b9530c7a46dd)

Company: https://www.keypedia.com/companies/ascension-health/aa996453-4934-4564-81a0-cff1afc9f1dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d